Prospect of the treatment of human gastric ulcers with orally administered epidermal growth factor.
Itoh
M
M
First Department of Internal Medicine, Nagoya City University Medical School, Japan.
Imai
S
S
Joh
T
T
Takeuchi
T
T
D000284:Administration, Oral; D000818:Animals; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002482:Cellulose / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004815:Epidermal Growth Factor / Q000008:administration & dosage / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D009853:Omeprazole / Q000627:therapeutic use; D051381:Rats; D013276:Stomach Ulcer / Q000188:drug therapy*; D013392:Sucralfate / Q000627:therapeutic use
D000897:Anti-Ulcer Agents; D013392:Sucralfate; D004815:Epidermal Growth Factor; D002482:Cellulose; C008079:hydroxypropylcellulose; D009853:Omeprazole